TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | 0 | -2 | 20 | 18 | 118 | 320 | 95 |
P | %wins | 100 | 0 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/12 19:21 | 12/8/12 | CPRX | Catalyst Pharmaceutical Partners, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Biomarin Pharmaceutical Inc | CA | T | P.d | 3,750 | 0.7500 | 0 | 5,000 | 300 | 6,667 | D | -56 | -61 | -25 | -70 | -73 | 7 | -14 | 0 | 0 | -2 | 20 | 18 | 118 | 320 | |
6/19/09 20:32 | 6/17/09 | LJPC | La Jolla Pharmaceutical Co | DE | Health | BioPrd | Biological Products, (No Diag | Biomarin Pharmaceutical Inc | CA | T | S.m | -1,201 | 0.2105 | 0 | -5,707 | -56 | 4,466 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |